Toward more effective antifungal therapy: the prospects of combination therapy

British Journal of Haematology
Dimitrios P Kontoyiannis, Russell E Lewis

Abstract

The availability of new antifungal agents with unique mechanisms of action and improved tolerability has widened the possibilities for the use of combination antifungal therapy for difficult-to-treat opportunistic mycoses. However, the use of this therapy is largely governed by empiricism, especially in patients with invasive mould infections, for whom there is a tremendous need to improve outcomes. Because of the difficulties associated with the design and conduct of clinical trials of combination antifungal therapy for opportunistic mycoses, the majority of the studies evaluating antifungal combinations are still performed in the laboratory or using animal models of infection. However, the methods used to assess combined antifungal effects in vitro and in animals are poorly standardized, and there is little evidence that data generated from these studies can be translated in treating human mycotic infections. Despite the empiricism of combination antifungal therapy, certain principles help guide the use and study of these regimens.

References

Jul 19, 1979·The New England Journal of Medicine·J E BennettD W Alling
Jul 1, 1991·Mycoses·H J SchmittD Armstrong
Jul 1, 1986·The Journal of Antimicrobial Chemotherapy·C E HughesD N Gerding
May 1, 1985·The Journal of Infectious Diseases·A Schaffner, P G Frick
Jan 1, 1965·Advances in Chemotherapy·E Frei, E J Freireich
Mar 1, 1995·Antimicrobial Agents and Chemotherapy·A M SugarM Picard
Oct 1, 1994·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·R A LarsenJ M Leedom
Sep 1, 1993·The Journal of Infectious Diseases·D GeorgeV T Andriole
Sep 1, 1995·Antimicrobial Agents and Chemotherapy·A M Sugar
Nov 1, 1995·Antimicrobial Agents and Chemotherapy·M A GhannoumR S Criddle
Sep 1, 1996·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·D W Denning
Jun 2, 1998·The Journal of Infectious Diseases·A M Sugar, X P Liu
Jun 24, 1998·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·H Mayanja-KizzaK Matsumoto
Aug 4, 1998·The Journal of Antimicrobial Chemotherapy·J Klastersky
May 4, 1999·International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases·P Trouiller, P L Olliaro
Apr 19, 2000·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·D A StevensG A Pankey
Apr 19, 2000·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·M S SaagW E Dismukes
Jul 29, 2000·The Journal of Infectious Diseases·A M LeMonteL J Wheat
Aug 22, 2000·Antimicrobial Agents and Chemotherapy·F BarchiesiG Scalise
Sep 19, 2000·Antimicrobial Agents and Chemotherapy·D P KontoyiannisK V Rolston
Jan 3, 2001·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·D CaillotH Guy
Feb 15, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·S J LinS M Teutsch
Aug 15, 2001·Pharmacotherapy·R E Lewis, D P Kontoyiannis
Oct 5, 2001·Clinical Microbiology Reviews·J H RexD W Warnock
Apr 10, 2002·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Dimitrios P Kontoyiannis
Apr 12, 2002·Lancet·Dimitrios P Kontoyiannis, Russell E Lewis
Jul 18, 2002·Antimicrobial Agents and Chemotherapy·William R KirkpatrickThomas F Patterson
Dec 20, 2002·The New England Journal of Medicine·Jorge Mora-DuarteUNKNOWN Caspofungin Invasive Candidiasis Study Group
May 15, 2003·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·John H RexUNKNOWN National Institute of Allergy and Infectious Diseases Mycoses Study Group
Jun 25, 2003·Antimicrobial Agents and Chemotherapy·John R GraybillRobert A Larsen
Oct 3, 2003·Diagnostic Microbiology and Infectious Disease·Dimitrios P KontoyiannisIssam I Raad

❮ Previous
Next ❯

Citations

Sep 13, 2006·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Jean Klastersky, Marianne Paesmans
Sep 22, 2007·Medical Mycology·Sevtap Arikan
Mar 3, 2006·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Jo-Anne H van BurikDimitrios P Kontoyiannis
Apr 19, 2006·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Jan PachlUNKNOWN Mycograb Invasive Candidiasis Study Group
Mar 26, 2010·The Journal of Antimicrobial Chemotherapy·Melanie W PoundRichard H Drew
Mar 24, 2009·Current Opinion in Pulmonary Medicine·Amparo Solé, Miguel Salavert
May 7, 2008·Antimicrobial Agents and Chemotherapy·Susanne PerkhoferCornelia Lass-Flörl
Feb 24, 2011·Antimicrobial Agents and Chemotherapy·Athanasios ChatzimoschouEmmanuel Roilides
Mar 25, 2008·Therapeutics and Clinical Risk Management·Javier PemánMiguel Gobernado
Jun 25, 2010·Current Fungal Infection Reports·Melissa D Johnson, John R Perfect
Feb 3, 2007·Expert Review of Anti-infective Therapy·Jorge GarbinoEmmanuel Roilides
May 1, 2013·Expert Review of Anti-infective Therapy·Nevin Hatipoglu, Husem Hatipoglu
Aug 19, 2005·Expert Review of Anti-infective Therapy·S R DoffmanJeremy S Brown
Jan 19, 2008·Expert Opinion on Pharmacotherapy·Shelley S MagillDavid W Warnock
Apr 2, 2008·Expert Opinion on Pharmacotherapy·James S Lewis, John R Graybill
Aug 7, 2009·Expert Opinion on Investigational Drugs·Susanne Perkhofer, Cornelia Lass-Flörl
Mar 23, 2010·Biochimica Et Biophysica Acta·Lynn McNaughtonDavid M LeMaster
Jul 18, 2008·Transplantation Reviews·Amparo Solé, Miguel Salavert
Mar 6, 2007·Best Practice & Research. Clinical Haematology·John R Wingard
May 24, 2006·Pharmacotherapy·Russell E Lewis
Jul 19, 2015·The Journal of Antimicrobial Chemotherapy·S DavoudiD P Kontoyiannis
May 21, 2015·European Journal of Clinical Investigation·Setareh DavoudiDimitrios P Kontoyiannis
Jul 2, 2016·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Thomas F PattersonJohn E Bennett
Jun 24, 2016·ChemMedChem·Huy X NgoSylvie Garneau-Tsodikova
Aug 5, 2014·Mycopathologia·Setareh DavoudiDimitrios P Kontoyiannis
Mar 30, 2017·The Journal of Antimicrobial Chemotherapy·Marie-Pierre LedouxRaoul Herbrecht
Feb 2, 2021·Infectious Diseases and Therapy·Francelise B CavassinFlávio Queiroz-Telles
Feb 10, 2021·Journal of Fungi·Anne-Laure BidaudEric Dannaoui

❮ Previous
Next ❯

Related Concepts

Related Feeds

Candidiasis

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Aspergillosis

Aspergillosis is the name given to a wide variety of diseases caused by infection by fungi of the genus Aspergillus. Aspergillosis occurs in chronic or acute forms which are clinically very distinct. Most cases of acute aspergillosis occur in patients with severely compromised immune systems. Chronic colonization or infection can cause complications in people with underlying respiratory illnesses. Discover the latest research on aspergillosis here.

Candidiasis (ASM)

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Aspergillosis (ASM)

Aspergillosis is the name given to a wide variety of diseases caused by infection by fungi of the genus Aspergillus. Aspergillosis occurs in chronic or acute forms which are clinically very distinct. Most cases of acute aspergillosis occur in patients with severely compromised immune systems. Chronic colonization or infection can cause complications in people with underlying respiratory illnesses. Discover the latest research on aspergillosis here.

Candida albicans

Candida albicans is an opportunistic, fungal pathogen of humans that frequently causes superficial infections of oral and vaginal mucosal surfaces of debilitated and susceptible individuals. Discover the latest research on Candida albicans here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.